Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding to Advance Manufacturing and Expand Commercialization of NX One Platform

The NX One platform is the first universally adoptable system to characterize, sort, and isolate single cells from biological samples Industry veteran William Rhodes joins Board of Directors SAN JOSE, Calif. -- Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation technologies, has raised an oversubscribed $30M Series A [...]

Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in the Fields of Leukemia Research and Molecular Genetics

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTG’s Therapeutics Scientific Advisory Board. Dr. Radich adds to the company’s [...]

Nicoya Extends Series A Financing With Additional $20 M to Meet Demand of Rapidly Growing Proteomics Industry

Nicoya’s Series A Extension is led by Whitecap Venture Partners, with participation from industry leader Agilent Technologies Inc (NYSE: A) KITCHENER, Ontario--Nicoya Lifesciences, a global leader in digital proteomics solutions, today announced a $20 million Series A extension led by Whitecap Venture Partners. The round included participation from strategic investor Agilent Technologies, a leading global [...]

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Company aims to democratise access to affordable biomedical research especially in cancer research and new drug development through its novel 3D cell culture platform Sydney, Australia — Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a AU$35m Series B funding round, led by Blackbird [...]

BIONANO GENOMICS ANNOUNCES THE LAUNCH OF VERSION 6.1 OF BIODISCOVERY’S NXCLINICAL SOFTWARE FOR GENOME ANALYSIS WITH EXPANDED CAPABILITIES FOR VISUALIZATION, INTERPRETATION AND REPORTING OF NEXT-GENERATION SEQUENCING DATA IN GENETIC DISEASES AND CANCER

SAN DIEGO -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announced the launch of version 6.1 of BioDiscovery’s NxClinical software with expanded capabilities for next-generation sequencing (NGS) data in genetic diseases and cancer. NxClinical is an [...]

Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding to Advance Manufacturing and Expand Commercialization of NX One Platform

The NX One platform is the first universally adoptable system to characterize, sort, and isolate single cells from biological samples - Industry veteran William Rhodes joins Board of Directors SAN JOSE, Calif. -- Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation technologies, has raised an oversubscribed $30M Series A financing [...]

Kewaunee Scientific Corporation Announces Continued Backlog Growth With Laurus Synthesis Turnkey Contract

STATESVILLE, N.C.—  Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announces that the Company’s Indian subsidiary has been awarded a significant turnkey contract from Laurus Synthesis (https://laurussynthesis.com), a subsidiary of Laurus Labs. Laurus Synthesis is a leading Contract Development & [...]

Michael Bolle Appointed Designated Chairman of Carl Zeiss AG Supervisory Board

The Carl Zeiss AG shareholders' meeting has appointed Dr. Michael Bolle the new Supervisory Board member to represent the sole shareholder the Carl Zeiss Foundation. He will be elected Chairman of the Supervisory Board of Carl Zeiss AG in January 2022. Dr. Bolle will succeed Dr. Dieter Kurz, whose mandate as Chairman of the Supervisory [...]

Menarini Silicon Biosystems announces new DEPArray™ PLUS application to identify mutations in FFPE tissue samples with low tumor cellularity

Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB’s DEPArray technology* to successfully recover low numbers of tumor cells from these difficult samples. The new FFPE Rescue Application* will provide pathology labs with a validated workflow to identify potentially targetable [...]

GenScript Biotech Expands to the United Kingdom with New Offices and Logistics Center

Oxford expansion supports U.K. customers with fast turnaround time on research products, and technical support OXFORD, England --GenScript Biotech Corp., a global biotechnology group, announced today that it has expanded operations in the United Kingdom with new offices and a fully functional logistics center in Oxford. The facility supports U.K. customers with fast delivery of [...]

Access IBO on Knowledge Center